Narrative Edge

KEYS

USD 260.61 +40.83% · 1Y
Latest: bull
Price
Oct 30 Nov 2 Nov 3 Nov 4 Nov 5 307.20 295.55 283.90 272.26 260.61
Oct 6 Oct 14 Oct 21 Oct 28 Nov 5 388.03 356.17 324.32 292.46 260.61
Aug 6 Aug 28 Sep 22 Oct 14 Nov 5 388.03 356.17 324.32 292.46 260.61
May 6 Jun 23 Aug 7 Sep 22 Nov 5 $400 388.03 356.17 324.32 292.46 260.61
Nov 6 Feb 6 May 8 Aug 10 Nov 5 $400 388.03 333.44 278.85 224.26 169.67
Nov 4 May 5 Nov 3 May 11 Nov 5 $400 384.64 320.24 255.83 191.43 127.02
Nov 6 Aug 5 May 5 Feb 9 Nov 5 $400 384.64 319.20 253.76 188.31 122.87
Full synthesis

Viewpoint Synthesis

Bull Thesis

KEYS is a broad-based AI infrastructure beneficiary with expanding test intensity across multiple speed transitions, supported by analyst upgrades and multi-year investment cycles.

1. Broad-based AI beneficiary with analyst upgrade

  • Morgan Stanley upgrade highlights broad AI infrastructure exposure, not single-architecture risk. ↴
  • AI revenue rising as customers accelerate 800G, expand 1.6T R&D, plan 3.2T, increasing test density. ↴
  • Mix shift drives greater test density and incremental margin leverage, supporting estimate upside. ↴

2. Multi-year test intensity expansion

  • Expanding test coverage across workflow with multi-year investment required for higher speeds. ↴
  • CPO adoption delayed to 2027+, reducing near-term disruption risk to KEYS' test equipment. ↴
  • Strong demand and scale-across tailwinds from OFC meetings reinforce growth outlook. ↴
Bear Thesis

No bearish evidence provided in sources.

No bear arguments extracted yet.
Opinion timeline

Opinion Timeline

Bull Plane
TIME
Bear Plane

Morgan Stanley upgraded the stock to Overweight, arguing the company is a broad-based beneficiary of AI infrastructure investment, not reliant on a single architecture.

PT $400 from $350
2026-07-13 Back to thesis

AI revenue is rising as customers accelerate 800G deployments, expand 1.6T R&D, and plan for 3.2T, supporting higher testing intensity.

2026-07-13 Back to thesis

Morgan Stanley sees estimate upside as the mix shift drives greater test density and incremental margin leverage.

2026-07-13 Back to thesis
2026-07-13
No bear argument in this report.

The company highlighted expanding test coverage across the workflow with multi-year investment required for higher speeds, indicating a growing market for its services.

2026-03-18 Back to thesis

CIEN/CSCO/GLW/KEYS/CLS/FN: Barclays OFC Meetings Highlight Strong Demand, Delayed CPO, and Scale- Across Tailwinds

2026-03-18 Back to thesis

Barclays says CSCO sees CPO adoption as longer-dated with demand still outpacing supply and no near-term OCS threat, while GLW expects CPO to emerge around 2027 with more material impact several years out; KEYS highlighted expanding test coverage across the...

2026-03-18 Back to thesis
2026-03-18
No bear argument in this report.
Sources and method

Research through 2026-07-13 · 2026-03-18 to 2026-07-13 · 2 source reports.

Price through 2026-11-05 · USD
Price cutoff for each chart range
RangePrices through
1W
1M
3M
6M
1Y
2Y
3Y
AI synthesis current. Synthesis as of 2026-10-01; evidence available through 2026-07-13. Verified source bindings; generated 2026-10-01, analyzed evidence through 2026-07-13.
Research coverage and method

Research through 2026-11-03. Artifact validity does not establish factual accuracy or research freshness.

Technical diagnostics
Research source: 2026-11-03 Processed through: 2026-11-03 Generated: 2026-11-05T21:55:38+00:00 · 0d ago Generation SHA: aedfe3ef5807 Service SHA: 50f2a97952e8